LLY
Eli Lilly and Company
Platform & Compounding FCF
A-
81.3 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
14.1%
-
Operating Margin Trend
+4.36 pp/yr
-
5yr Avg ROE
36.4%
-
5yr Share-Count CAGR
-1.5%
-
5yr Revenue CAGR
23.2%
-
5yr EPS CAGR
40.7%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
8.1%
-
5yr FCF/NI Conversion
0.31x
-
Net Debt / EBITDA
1.26x
-
Interest Coverage (EBIT/Int)
33.16x
-
Altman Z-Score
9.10
Stability
Weight: 5%
C-
48
-
EPS Volatility (σ/μ)
0.81
-
Piotroski F-Score
6
-
Negative-Revenue Years (5)
0/5
5 of 5 gurus held; 1 added; 4 trimmed; 1 full exit.
- Holders
- 5
- Avg Δ position
-
-3.2%
- New buys
- 0
- Full exits
- 1